JAMA points out that "these adverse events, although rare, must be considered by patients who are thinking about using the drugs for weight loss because the risk-benefit calculus for this group might differ from that of those who use them for diabetes" [20]
Recalls & Warnings September 23, 2014 Maker of Joint and Weight Products Warned for Hidden Drugs, Manufacturing Violations On September 15, 2014, the FDA issued a warning letter to West Coast Laboratories, Inc., because the company's joint health supplements, Super ArthGold and Pro ArthMax, were found to contain hidden drugs
Insurance is not required for sermorelin
Rajendram, R
June 1, 2026: More Than 100 Lawsuits Join GLP-1 MDL as Novo Nordisk Asks for Dismissal of Plaintiffs Experts There are now 3,763 in the MDL involving Ozempic and other GLP-1 drugs, an increase of 127 from May numbers